Overview

The pan-Canadian Pharmaceutical Alliance (pCPA) brings together provincial, territorial, and federal governments for the purpose of increasing and managing access to clinically relevant and cost-effective medicines. Through collective negotiations, the pCPA has realized overall savings for governments of $3.94 billion annually for brand name drugs and $935 million annually for generic drugs totaling $4.87 billion annually (as of April 1, 2025). The pCPA offers a 100% remote (within Canada) work environment.

About the role

The economist is accountable to the senior manager, Analytics, by providing expertise and leadership to support pCPA’s decision-making for the planning, coordination, and management of negotiations using health economic evaluation and other financial analyses to obtain the best possible value and maximize drug plans’ investment in the health care system.

The economist holds a degree in economics, finance, ...